Literature DB >> 20711216

Novel approaches for the molecular classification of prostate cancer.

Robert H Getzenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20711216      PMCID： PMC3739323          DOI： 10.1038/aja.2010.95

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  3 in total

1.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

3.  Molecular analysis of multifocal prostate cancer lesions.

Authors:  E T Ruijter; G J Miller; C A van de Kaa; A van Bokhoven; M J Bussemakers; F M Debruyne; D J Ruiter; J A Schalken
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996
  3 in total
  1 in total

1.  Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.

Authors:  Aleyde Van Eynde; Kirill Litovkin; Mathieu Bollen
Journal:  Asian J Androl       Date:  2010-11-22       Impact factor: 3.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.